Company Filing History:

7 out of 2,538

Warner-lambert Company

patents

Merck Sharp + Dohme Corp.

Years Active: 1977-2013

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE44205 - Adenosine Areceptor antagonists (2013-05-06),

2. 7067655 - Adenosine A2a receptor antagonists (2006-06-27),

3. 6897216 - Adenosine A2a receptor antagonists (2005-05-24),

4. 6630475 - Adenosine A2a receptor antagonists (2003-10-07),

5. 5393755 - Polycyclic guanine derivatives (1995-02-28),

6. 4723029 - Organic acid-substituted guanidine anthelmintics (1988-02-02),

7. 4701447 - N-((2-nitro)phenyl)-N' (organic acid) guanidine anthelmintics (1987-10-20),

8. 4154735 - Bis 2-[(dialkylamino)methyl]indoles (1979-05-15),

9. 4153711 - 3-(3H-Pyrazol-3-one)-2-(disubstituted aminomethyl)indoles and (1979-05-08),

10. 4140858 - 3-(1H-imidazol-1-ylmethyl)-2-(disubstitutedaminomethyl)indoles and a (1979-02-20),

11. 4132792 - Bis(2-[(disubstituted amino)methyl]-1H-indole) compounds (1979-01-02),

12. 4116964 - 2-[(N-2-pyridylcarbamoyl)methyl]saccharin (1978-09-26),

13. 4074048 - Process for the preparation of (1978-02-14),

14. 4013686 - 4-(1-Pyrrolidinyl)-2H-1-benzothiopyran-1,1-dioxide (1977-03-22),

15. 4007203 - 4-(1-Pyrolidenyl)-2H-1-benzothiopyran-3-carboxanilide (1977-02-08),

Title: The Innovations of Neil A Lindo

Introduction

Neil A Lindo, an accomplished inventor based in New Providence, NJ, has made significant contributions to the field of pharmaceuticals, particularly concerning treatments for Parkinson's disease. With a remarkable portfolio of 15 patents, Lindo’s work showcases his deep understanding of medicinal chemistry and innovation.

Latest Patents

Among Lindo's most recent patents are those focusing on Adenosine A2a receptor antagonists. These compounds are crucial in developing treatments for Parkinson's disease, providing a novel approach to address the complex challenges associated with this condition. The structural formula and variants detailed in his patents highlight the intricacies involved in creating effective pharmaceutical compounds, demonstrating Lindo's expertise in this specialized area of research.

Career Highlights

Neil A Lindo has held vital positions at notable companies throughout his career, including Warner-Lambert Company and Schering Corporation. His tenure at these organizations allowed him to collaborate with leading minds in pharmaceutical research, accelerating innovative developments in drug formulation and therapeutic applications.

Collaborations

Throughout his professional journey, Lindo has partnered with esteemed colleagues such as Harold Zinnes and Bernard R Neustadt. These collaborations have enriched his research endeavors and contributed significantly to the advancement of pharmaceutical sciences, particularly in the development of new compounds and treatment methodologies.

Conclusion

In summary, Neil A Lindo's inventive spirit and commitment to healthcare innovation have positioned him as a prominent figure in the pharmaceutical industry. His contributions, particularly in the realm of Parkinson's disease treatment, underscore the importance of continued research and development in this critical area. As he continues to forge ahead with new inventions, the legacy of his work promises to impact countless lives.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com